Literature DB >> 6668489

Analysis of survival by tumor response.

J R Anderson, K C Cain, R D Gelber.   

Abstract

The common practice of comparing the survival of responders and nonresponders when reporting the results of cancer chemotherapy treatment is investigated. The usual method of comparing responders and nonresponders is biased in favor of responders, and these results are frequently misinterpreted as providing evidence that response prolongs survival, or that the treatment under study is effective. Two valid methods for comparing responders and nonresponders are discussed and recommendations are made concerning the analysis of survival by response. A comparison of survival by response category may be useful descriptively, but such a comparison should not be used for inference concerning treatment effectiveness.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6668489     DOI： 10.1200/JCO.1983.1.11.710

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


  277 in total

1.  The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.

Authors:  Jan-Henning Klusmann; Dirk Reinhardt; Martin Zimmermann; Bernhard Kremens; Josef Vormoor; Michael Dworzak; Ursula Creutzig; Thomas Klingebiel
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.

Authors:  Hirozumi Sano; Akira Shimada; Tomohiko Taki; Chisato Murata; Myoung-Ja Park; Manabu Sotomatsu; Ken Tabuchi; Akio Tawa; Ryoji Kobayashi; Keizo Horibe; Masahiro Tsuchida; Ryoji Hanada; Ichiro Tsukimoto; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2012-03-10       Impact factor: 2.490

3.  High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

Authors:  Ira J Dunkel; Sharon L Gardner; James H Garvin; Stewart Goldman; Weiji Shi; Jonathan L Finlay
Journal:  Neuro Oncol       Date:  2010-01-11       Impact factor: 12.300

4.  Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup.

Authors:  Amy E Krambeck; Andrew D Rule; Xujian Li; Eric J Bergstralh; Matthew T Gettman; John C Lieske
Journal:  J Urol       Date:  2010-11-13       Impact factor: 7.450

5.  Do surgical margin and local recurrence influence survival in soft tissue sarcomas?

Authors:  Eduardo N Novais; Bahtiyar Demiralp; Joseph Alderete; Melissa C Larson; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

6.  Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

Authors:  Melissa H Kong; Linda K Shaw; Christopher O'Connor; Robert M Califf; Michael A Blazing; Sana M Al-Khatib
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

7.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

8.  Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group.

Authors:  Yoshikiyo Ito; Toshihiro Miyamoto; Tomohiko Kamimura; Ken Takase; Hideho Henzan; Yasuo Sugio; Koji Kato; Yuju Ohno; Tetsuya Eto; Takanori Teshima; Koichi Akashi
Journal:  Int J Hematol       Date:  2013-09-17       Impact factor: 2.490

9.  Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.

Authors:  Arianna Barbetta; Meier Hsu; Kay See Tan; Dessislava Stefanova; Koby Herman; Prasad S Adusumilli; Manjit S Bains; Matthew J Bott; James M Isbell; Yelena Y Janjigian; Geoffrey Y Ku; Bernard J Park; Abraham J Wu; David R Jones; Daniela Molena
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-15       Impact factor: 5.209

10.  PET scans as a predictive marker of survival in advanced colorectal cancer.

Authors:  Minsig Choi; Sri Lakshmi S Kollepara; Lance K Heilbrun; Daryn Smith; Anthony F Shields; Philip A Philip
Journal:  Clin Colorectal Cancer       Date:  2014-10-23       Impact factor: 4.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.